LL-37 vs Oxytocin
Updated October 16, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of LL-37 and Oxytocin (also searched as Oxytocin vs LL-37) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
LL-37 centers on healing, while Oxytocin leans toward neuro. On indexed research, Oxytocin is ahead (LL-37: 35 studies, Human evidence; Oxytocin: 40, Human clinical). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •LL-37 is strongest for healing; Oxytocin for neuro.
- •Evidence: LL-37 Human evidence (35 studies) vs Oxytocin Human clinical (40).
- •Check the FDA-approval status chips above before assuming a legal use pathway.
Effect profiles, overlaid
At a glance
LL-37 vs Oxytocin: side-by-side
| Metric | LL-37 | Oxytocin |
|---|---|---|
| Class | Immune | Neuro |
| Regulatory status | Research use only | FDA-approved |
| Evidence grade | Human evidence | Human clinical |
| Studies indexed | 35 | 40 |
| Research level | Well Studied | FDA Approved |
| Strongest effect | Healing & recovery | Neuro & mood |
| Healing & recovery | 5.0▲ | 2.0 |
| Muscle & body comp | 0.0 | 1.0▲ |
| Metabolic & appetite | 0.0 | 1.0▲ |
| Neuro & mood | 0.0 | 5.0▲ |
| Sleep & circadian | 0.0 | 2.0▲ |
| Inflammation & immune | 4.0▲ | 1.0 |
| Skin & aesthetics | 2.0▲ | 1.0 |
▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).
Mechanism & pharmacokinetics
| Property | LL-37 | Oxytocin |
|---|---|---|
| Mechanism | Disrupts microbial membranes, modulates immune responses | Oxytocin receptor agonist |
| Route | — | Intravenous injection; Intranasal administration |
| Half-life | — | ~3-5 min |
| Time to peak | — | ~30 min |
| Duration of action | — | 1-2 hours |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is LL-37?
LL-37 is a human cathelicidin antimicrobial peptide that plays a crucial role in the innate immune response. It is produced by various cells, including epithelial cells and neutrophils, and exhibits a broad spectrum of biological activities, including antimicrobial, immunomodulatory, and wound healing properties. LL-37 interacts with a variety of pathogens, including bacteria, viruses, and fungi, contributing to the host's defense mechanisms.
Full LL-37 profile, mechanism & studies →What is Oxytocin?
Oxytocin is a neuropeptide synthesized in the hypothalamus and released by the posterior pituitary gland. It plays a significant role in various physiological and behavioral processes, including social bonding, reproductive behaviors, emotional regulation, childbirth, and lactation. The mechanisms of action of oxytocin involve its binding to specific receptors in the brain and peripheral tissues, influencing neural circuits associated with social cognition, attachment, and stress response.
Full Oxytocin profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | LL-37 | 5.0/5 effect signal |
| Muscle | Oxytocin | 1.0/5 effect signal |
| Metabolic | Oxytocin | 1.0/5 effect signal |
| Neuro | Oxytocin | 5.0/5 effect signal |
| Sleep | Oxytocin | 2.0/5 effect signal |
| Inflammation | LL-37 | 4.0/5 effect signal |
| Skin | LL-37 | 2.0/5 effect signal |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack LL-37 and Oxytocin?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because at least one is a research-use compound, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
LL-37 vs Oxytocin: side effects
No community-reported effects logged yet.
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
LL-37 has 35 approved studies indexed (Human evidence), and Oxytocin has 40 (Human clinical). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is LL-37 or Oxytocin better?
It depends on your goal. LL-37 is strongest for healing; Oxytocin for neuro. Oxytocin has more indexed studies (40). See the goal-by-goal breakdown above.
Is LL-37 or Oxytocin better for weight loss?
Oxytocin shows the stronger metabolic & appetite profile (1.0/5) in the AI-assigned effect profile — though weight-loss outcomes depend on the individual and the evidence base.
Is LL-37 or Oxytocin better for muscle?
Oxytocin leads on the muscle & body-composition axis (1.0/5).
Which has more research, LL-37 or Oxytocin?
LL-37 has 35 approved studies indexed (Human evidence); Oxytocin has 40 (Human clinical). Higher counts mean more to read, not proven superiority.
Can you stack LL-37 and Oxytocin?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of LL-37 vs Oxytocin?
LL-37: no community-reported effects logged yet. Oxytocin: none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is LL-37 or Oxytocin FDA-approved?
LL-37 is a research-use compound and is not FDA-approved. Oxytocin is FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is Oxytocin better than LL-37?
For neuro, Oxytocin has the edge; for healing, LL-37 does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
Approval status varies (see the chips at the top). FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed October 16, 2026.